デフォルト表紙
市場調査レポート
商品コード
1437514

ロラタジン市場:グレードタイプ別、剤形別、最終用途別、国別、地域別-2024-2032年の産業分析、市場規模、市場シェア、予測

Loratadine Market, By Grade Type, By Dosage Form, By End-Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 260 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.31円
ロラタジン市場:グレードタイプ別、剤形別、最終用途別、国別、地域別-2024-2032年の産業分析、市場規模、市場シェア、予測
出版日: 2024年02月20日
発行: AnalystView Market Insights
ページ情報: 英文 260 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

ロラタジン市場規模は2023年に1億5,550万米ドルとなり、2024年から2032年にかけてCAGR 2.8%で拡大

ロラタジン市場-市場力学

複数のアレルギーの蔓延が市場需要を促進

皮膚アレルギー、アレルギー性鼻炎、アレルギー性喘息、アレルギー性結膜炎、アレルギー性鼻炎など、多くのアレルギー疾患の頻度が増加しているため、疾患管理における効果的な治療法の需要が高まるとみられます。遺伝的素因、ライフスタイルの変化、環境変数が、高い疾病負担の原因となっています。例えば、米国アレルギー・喘息・免疫学会(American Academy College of Allergy, Asthma &Immunology)の報告によると、2021年には世界中の18~44歳の25.7%以上の人が季節性アレルギーを経験するといいます。また、花粉症は18歳以上のアメリカ人の7.8%以上が罹患しています。近い将来、高所得国および中所得国における疾病負担の増加と人口動態の変化が、市場需要を牽引すると予想されます。

ロラタジン市場-主要インサイト

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間(2024-2032年)に約2.8%のCAGRで毎年成長すると予測されています。

グレードタイプ別では、USP標準グレードが市場を独占しています。

剤形別では、錠剤が2023年に最大の市場シェアを占める

エンドユーズセグメンテーションに基づくと、オンライン薬局セグメントが予測期間中に最も高いCAGRで成長すると予測されています。

地域別では、北米が2023年の売上高でトップ

ロラタジン市場-セグメンテーション分析:

ロラタジンの世界市場は、グレードタイプ、剤形、最終用途、地域に基づいてセグメント化されます。

市場はグレードタイプに基づいて4つのカテゴリーに分けられる:EP標準グレード、USP標準グレード、医薬標準グレード、その他です。USP標準グレードのカテゴリーが市場を独占しています。USP標準グレードは、品質と安全性に関する規則を遵守することに強い重点を置いており、その結果、消費者の嗜好と採用率が高まる。

市場は剤形によって4つのカテゴリーに分けられる:カプセル剤、錠剤、シロップ剤、その他です。2023年には錠剤セグメントが最大の市場シェアを占め、予測期間中も同じパターンが続くと予想されます。その主な理由は、大型で認可された錠剤の形態が容易に入手でき、投与が簡単であるためです。

市場は最終用途に基づいて3つのカテゴリーに分類される:小売薬局、病院薬局、オンライン薬局です。オンライン薬局セグメントは、予測期間中に最も高いCAGRで成長すると予想されます。このセグメントの成長は、利便性、アクセスのしやすさ、デジタルヘルスソリューションへの嗜好の高まりといった要因によるものです。

ロラタジン市場-地理的洞察

地理的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。北米はアレルギーの罹患率が高く、ヘルスケアシステムが確立されており、ロラタジンの生産・販売部門の主要参入企業も多いため、予測期間中は市場をリードすると予想されます。さらに、活発なパイプラインとロラタジンの適応性の向上が、予測期間中の地域の成長を促進すると予測されています。The Asthma and Allergy Foundation of Americaの2022年の調査では、約25の主要都市がアレルギー反応のハイリスクカテゴリーに分類されるとしています。

ロラタジン市場-競合情勢:

市場で事業を展開する主要企業は、Cadila Pharmaceuticals、Perrigo Company plc、Bayer AG、Morepen Laboratories Ltd、Viatris Inc.、Pfizer Inc.、Sun Pharmaceutical Industries Limited、Lannett、東京化成工業株式会社、Claritin、Merck KGaA、Cipla Inc.などです。新市場へのアクセスを得るため、市場参入企業は新製品の創出、資金調達や投資、M&A、その他の戦略的提携など、さまざまな戦略的イニシアチブを継続的に追求しています。

目次

第1章 ロラタジン市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 ロラタジンの主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 ロラタジン産業調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 ロラタジン市場:COVID-19症の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 ロラタジン市場情勢

  • ロラタジン市場シェア分析 2023年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 ロラタジン市場-グレードタイプ別

  • 概要
    • グレード別セグメントシェア分析
    • EPスタンダードグレード
    • USPスタンダードグレード
    • 医学標準グレード
    • その他

第8章 ロラタジン市場-剤形別

  • 概要
    • 剤形別セグメントシェア分析
    • カプセル
    • タブレット
    • シロップ
    • その他

第9章 ロラタジン市場-最終用途別

  • 概要
    • 最終用途別のセグメントシェア分析
    • 小売薬局
    • 病院薬局
    • オンライン薬局

第10章 ロラタジン市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋(APAC)
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- ロラタジン業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Cadila Pharmaceuticals
    • Perrigo Company plc
    • Bayer AG
    • Morepen Laboratories Ltd
    • Viatris Inc.
    • Pfizer Inc.
    • Sun Pharmaceutical Industries Limited
    • Lannett
    • Tokyo Chemical Industry Co., Ltd.
    • Claritin
    • Merck KGaA
    • Cipla Inc

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Loratadine Market: Grade Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Grade Type
  • TABLE Global Loratadine Market, by Grade Type 2019-2032 (USD Million)
  • TABLE Loratadine Market: Dosage Form Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Dosage Form
  • TABLE Global Loratadine Market, by Dosage Form 2019-2032 (USD Million)
  • TABLE Loratadine Market: End-UseSnapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-Use
  • TABLE Global Loratadine Market, by End-Use2019-2032 (USD Million)
  • TABLE Loratadine Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Loratadine Market, by Region 2019-2032 (USD Million)
  • TABLE North America Loratadine Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Loratadine Market, by Grade Type, 2019-2032 (USD Million)
  • TABLE North America Loratadine Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE North America Loratadine Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Europe Loratadine Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Loratadine Market, by Grade Type, 2019-2032 (USD Million)
  • TABLE Europe Loratadine Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE Europe Loratadine Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Asia Pacific Loratadine Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Loratadine Market, by Grade Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Loratadine Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE Asia Pacific Loratadine Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Latin America Loratadine Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Loratadine Market, by Grade Type, 2019-2032 (USD Million)
  • TABLE Latin America Loratadine Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE Latin America Loratadine Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Loratadine Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Loratadine Market, by Grade Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Loratadine Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Loratadine Market, by End-Use, 2019-2032 (USD Million)
目次
Product Code: ANV2232

REPORT HIGHLIGHT

Loratadine Market size was valued at USD 155.5 Million in 2023, expanding at a CAGR of 2.8% from 2024 to 2032.

The short-term relief of hay fever symptoms, which are caused by allergies to dust, pollen, or other airborne particles, is achieved with the use of loratadine. Sneezing, runny nose, and itchy eyes, nose, or throat are some of these symptoms. Additionally, loratadine is utilized to relieve hive-related redness and itching. But loratadine doesn't stop allergic skin responses like hives. Loratadine belongs to the group of drugs known as antihistamines. It functions by preventing the body's natural production of histamine, which is a chemical that triggers allergic reactions.

Loratadine Market- Market Dynamics

Growing prevalence of several allergies to propel market demand

Effective treatments in disease management will be in high demand due to the increasing frequency of many allergic disorders, including skin allergies, allergic rhinitis, allergic asthma, allergic conjunctivitis, and allergic rhinitis. Genetic predispositions, changing lifestyles, and environmental variables are responsible for the high illness burden. For instance, the American Academy College of Allergy, Asthma & Immunology reports that in 2021, over 25.7% of people worldwide in the 18-44 age range experienced seasonal allergies. Also, hay fever affects more than 7.8% of Americans who are 18 years of age and older. In the near future, it is thus expected that the rising illness burden and demographic change in high- and middle-income nations would drive market demand.

Loratadine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 2.8% over the forecast period (2024-2032)

Based on grade type segmentation, the USP Standard Grade category dominates the market

Based on the dosage form segmentation, tablets segment held the largest market share in 2023

Based on end-use segmentation, the online pharmacy segment is expected to grow at the highest CAGR during the forecast period

Based on region, North America was the leading revenue generator in 2023

Loratadine Market- Segmentation Analysis:

The Global Loratadine Market is segmented based on Grade Type, Dosage Form, End-Use, and Region.

The market is divided into four categories based on grade type: EP Standard Grade, USP Standard Grade, Medicine Standard Grade and Others. The USP Standard Grade category dominates the market. The USP standard grade places a strong focus on adhering to quality and safety rules, which in turn increases consumer preference and adoption rates.

The market is divided into four categories based on the dosage form: Capsules, Tablets, Syrup and Others. The tablets segment held the largest market share in 2023 and is expected to continue the same pattern during the forecast period. This is mostly because large, authorized pill forms are readily available and are simple to administer.

The market is divided into three categories based on end-use: Retail Pharmacy, Hospital Pharmacy and Online Pharmacy. The online pharmacy segment is expected to grow at the highest CAGR during the forecast period. The segment growth is attributed to factors such as convenience, accessibility, and a growing preference for digital health solutions.

Loratadine Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to lead the market during the forecast period because the area has a high incidence of allergies, a well-established healthcare system, and major participants in the loratadine production and marketing sectors. Moreover, it is projected that active pipelines and loratadine's increasing adaptability would promote regional growth over the projection period. The Asthma and Allergy Foundation of America's 2022 study states that about 25 major cities fall into the high-risk category for allergic reactions.

Loratadine Market- Competitive Landscape:

The key players operating in the market are Cadila Pharmaceuticals, Perrigo Company plc, Bayer AG, Morepen Laboratories Ltd, Viatris Inc., Pfizer Inc., Sun Pharmaceutical Industries Limited, Lannett, Tokyo Chemical Industry Co., Ltd., Claritin, Merck KGaA, Cipla Inc. To obtain access to new markets, market players are continuously pursuing a variety of strategic initiatives, including the creation of new products, funding and investments, mergers and acquisitions, and other strategic partnerships.

Recent Developments:

In January 2022, Institut d'Investigacio Biomedica de Bellvitge is sponsoring a clinical trial called "Effect of Loratadine in Lymphangioleiomyomatosis (LORALAM)" to evaluate the safety and possible advantages of loratadine in LAM, a rare and fatal disease marked by progressive cystic lung destruction.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LORATADINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Cadila Pharmaceuticals

Perrigo Company plc

Bayer AG

Morepen Laboratories Ltd

Viatris Inc.

Pfizer Inc.

Sun Pharmaceutical Industries Limited

Lannett

Tokyo Chemical Industry Co., Ltd.

Claritin

Merck KGaA

Cipla Inc

GLOBAL LORATADINE MARKET, BY GRADE TYPE- MARKET ANALYSIS, 2019 - 2032

  • EP Standard Grade
  • USP Standard Grade
  • Medicine Standard Grade
  • Others

GLOBAL LORATADINE MARKET, BY DOSAGE FORM- MARKET ANALYSIS, 2019 - 2032

  • Capsules
  • Tablets
  • Syrup
  • Others

GLOBAL LORATADINE MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy

GLOBAL LORATADINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Loratadine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Loratadine Market Snippet by Grade Type
    • 2.1.2. Loratadine Market Snippet by Dosage Form
    • 2.1.3. Loratadine Market Snippet by End-Use
    • 2.1.4. Loratadine Market Snippet by Country
    • 2.1.5. Loratadine Market Snippet by Region
  • 2.2. Competitive Insights

3. Loratadine Key Market Trends

  • 3.1. Loratadine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Loratadine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Loratadine Market Opportunities
  • 3.4. Loratadine Market Future Trends

4. Loratadine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Loratadine Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Loratadine Market Landscape

  • 6.1. Loratadine Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Loratadine Market - By Grade Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Grade Type, 2023 & 2032 (%)
    • 7.1.2. EP Standard Grade
    • 7.1.3. USP Standard Grade
    • 7.1.4. Medicine Standard Grade
    • 7.1.5. Others

8. Loratadine Market - By Dosage Form

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Dosage Form, 2023 & 2032 (%)
    • 8.1.2. Capsules
    • 8.1.3. Tablets
    • 8.1.4. Syrup
    • 8.1.5. Others

9. Loratadine Market - By End-Use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-Use, 2023 & 2032 (%)
    • 9.1.2. Retail Pharmacy
    • 9.1.3. Hospital Pharmacy
    • 9.1.4. Online Pharmacy

10. Loratadine Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Loratadine Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Loratadine Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Loratadine Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Loratadine Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Loratadine Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Loratadine Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Cadila Pharmaceuticals
    • 11.2.2. Perrigo Company plc
    • 11.2.3. Bayer AG
    • 11.2.4. Morepen Laboratories Ltd
    • 11.2.5. Viatris Inc.
    • 11.2.6. Pfizer Inc.
    • 11.2.7. Sun Pharmaceutical Industries Limited
    • 11.2.8. Lannett
    • 11.2.9. Tokyo Chemical Industry Co., Ltd.
    • 11.2.10. Claritin
    • 11.2.11. Merck KGaA
    • 11.2.12. Cipla Inc

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us